Your browser doesn't support javascript.
loading
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination.
Sokal, Aurélien; Bastard, Paul; Chappert, Pascal; Barba-Spaeth, Giovanna; Fourati, Slim; Vanderberghe, Alexis; Lagouge-Roussey, Pauline; Meyts, Isabelle; Gervais, Adrian; Bouvier-Alias, Magali; Azzaoui, Imane; Fernández, Ignacio; de la Selle, Andréa; Zhang, Qian; Bizien, Lucy; Pellier, Isabelle; Linglart, Agnès; Rothenbuhler, Anya; Marcoux, Estelle; Anxionnat, Raphael; Cheikh, Nathalie; Léger, Juliane; Amador-Borrero, Blanca; Fouyssac, Fanny; Menut, Vanessa; Goffard, Jean-Christophe; Storey, Caroline; Demily, Caroline; Mallebranche, Coralie; Troya, Jesus; Pujol, Aurora; Zins, Marie; Tiberghien, Pierre; Gray, Paul E; McNaughton, Peter; Sullivan, Anna; Peake, Jane; Levy, Romain; Languille, Laetitia; Rodiguez-Gallego, Carlos; Boisson, Bertrand; Gallien, Sébastien; Neven, Bénédicte; Michel, Marc; Godeau, Bertrand; Abel, Laurent; Rey, Felix A; Weill, Jean-Claude; Reynaud, Claude-Agnès; Tangye, Stuart G.
Afiliación
  • Sokal A; Necker Enfants Malades Institute, INSERM U1151/CNRS UMR 8253, Action thématique incitative sur programme-Avenir Team Auto-Immune and Immune B cell, University Paris Cité, University Paris-Est-Créteil, Créteil, France.
  • Bastard P; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • Chappert P; Imagine Institute, University Paris Cité, Paris, France.
  • Barba-Spaeth G; Department of Pediatrics, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Fourati S; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
  • Vanderberghe A; Necker Enfants Malades Institute, INSERM U1151/CNRS UMR 8253, Action thématique incitative sur programme-Avenir Team Auto-Immune and Immune B cell, University Paris Cité, University Paris-Est-Créteil, Créteil, France.
  • Lagouge-Roussey P; INSERM U955, team 2. Mondor Biomedical Research Institute, Paris-Est Créteil University, Créteil, France.
  • Meyts I; Institut Pasteur, University Paris Cité, CNRS UMR 3569, Structural Virology Unit, Paris, France.
  • Gervais A; Virology, Bacteriology, Hygiene and Mycology-Parasitology, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, France.
  • Bouvier-Alias M; INSERM U955, team 18. Mondor Biomedical Research Institute, Paris-Est Créteil University, Créteil, France.
  • Azzaoui I; INSERM U955, team 2. Mondor Biomedical Research Institute, Paris-Est Créteil University, Créteil, France.
  • Fernández I; Departement of Internal Medicine, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Paris-Est Créteil University, Créteil, France.
  • de la Selle A; INSERM U955, team 2. Mondor Biomedical Research Institute, Paris-Est Créteil University, Créteil, France.
  • Zhang Q; Departement of Internal Medicine, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Paris-Est Créteil University, Créteil, France.
  • Bizien L; Department of Immunology and Microbiology, Laboratory for Inborn Errors of Immunity, Department of Pediatrics, University Hospitals Leuven and Katholieke Universiteit Leuven, Leuven, Belgium.
  • Pellier I; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • Linglart A; Imagine Institute, University Paris Cité, Paris, France.
  • Rothenbuhler A; Virology, Bacteriology, Hygiene and Mycology-Parasitology, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, France.
  • Marcoux E; INSERM U955, team 18. Mondor Biomedical Research Institute, Paris-Est Créteil University, Créteil, France.
  • Anxionnat R; INSERM U955, team 2. Mondor Biomedical Research Institute, Paris-Est Créteil University, Créteil, France.
  • Cheikh N; Departement of Internal Medicine, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Paris-Est Créteil University, Créteil, France.
  • Léger J; Institut Pasteur, University Paris Cité, CNRS UMR 3569, Structural Virology Unit, Paris, France.
  • Amador-Borrero B; Necker Enfants Malades Institute, INSERM U1151/CNRS UMR 8253, Action thématique incitative sur programme-Avenir Team Auto-Immune and Immune B cell, University Paris Cité, University Paris-Est-Créteil, Créteil, France.
  • Fouyssac F; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • Menut V; Imagine Institute, University Paris Cité, Paris, France.
  • Goffard JC; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
  • Storey C; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • Demily C; Imagine Institute, University Paris Cité, Paris, France.
  • Mallebranche C; Pediatric Immuno-hemato-oncology Unit, Centre Hospitalier Universitaire Angers, Angers, France.
  • Troya J; University Angers, Nantes university, Centre Hospitalier Universitaire Angers, INSERM, CRCI2NA, SFR ICAT, Angers, France.
  • Pujol A; Departement of Pediatric Endocrinology, Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris, Paris Saclay University, Le Kremlin-Bicêtre, France.
  • Zins M; Departement of Pediatric Endocrinology, Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris, Paris Saclay University, Le Kremlin-Bicêtre, France.
  • Tiberghien P; Department of Pediatrics, Nord Franche Comté Hospital, Trévenans, France.
  • Gray PE; Department of Pediatrics, Besançon Hospital, Besançon, France.
  • McNaughton P; Department of Pediatrics, Besançon Hospital, Besançon, France.
  • Sullivan A; Department of Pediatric Endocrinology and INSERM NeuroDiderot, Referral Centre for Endocrine, Growth and Development diseases, Assistance Publique-Hôpitaux de Paris Nord, University of Paris, Paris, France.
  • Peake J; Department of Internal Medicine, Lariboisière University Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris, Paris, France.
  • Levy R; Department of Pediatric Hemato-oncology, Childrens Hospital, Nancy University Hospital, Nancy, France.
  • Languille L; Department of Pediatrics, Mother-Child Hospital, Nantes, France.
  • Rodiguez-Gallego C; Department of Internal Medicine, Université Libre de Bruxelles-Hôpitaux Universitaire de Bruxelles, Erasme Hospital, Bruxelles, Belgique.
  • Boisson B; Departement of Pediatric Endocrinology, Robert Debré Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Gallien S; GénoPsy Referral Center, Centre de Référence de Maladies Rares Rare Disease with Psychiatric Epression, Le Vinatier Hospital, Bron, France.
  • Neven B; Pediatric Immuno-hemato-oncology Unit, Centre Hospitalier Universitaire Angers, Angers, France.
  • Michel M; University Angers, Nantes university, Centre Hospitalier Universitaire Angers, INSERM, CRCI2NA, SFR ICAT, Angers, France.
  • Godeau B; Department of Internal Medicine, Infanta Leonor University Hospital, Madrid, Spain.
  • Abel L; Neurometabolic Diseases Laboratory, Institut d'Investigació Biomèdica de Bellvitge-Hospital Duran i Reynals, Centro de Investigación Biomédica en Red de Enfermededas Raras U759, and Catalan Institution of Research and Advanced Studies, Barcelona, Spain.
  • Rey FA; University of Paris, University of Paris-Saclay, Université de Versailles Saint-Quentin-en-Yvelines, INSERM UMS11, Villejuif, France.
  • Weill JC; French Blood Agency, La Plaine Saint-Denis, France.
  • Reynaud CA; UMR1098 RIGHT, INSERM, French Blood Agency, Franche-Comté University, Besançon, France.
  • Tangye SG; Department of Immunology and Infectious Diseases, Sydney Children's Hospital, Randwick, New South Wales, Australia.
J Exp Med ; 220(1)2023 01 02.
Article en En | MEDLINE | ID: mdl-36342455
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Linfocitos B / Interferón Tipo I / Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: J Exp Med Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Linfocitos B / Interferón Tipo I / Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: J Exp Med Año: 2023 Tipo del documento: Article País de afiliación: Francia